{
     "PMID": "29253605",
     "OWN": "NLM",
     "STAT": "Publisher",
     "LR": "20180206",
     "IS": "1873-2747 (Electronic) 0361-9230 (Linking)",
     "VI": "137",
     "DP": "2017 Dec 15",
     "TI": "Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events.",
     "PG": "204-216",
     "LID": "S0361-9230(17)30392-1 [pii] 10.1016/j.brainresbull.2017.12.005 [doi]",
     "AB": "Despite decades of research, the fundamental neurochemical and molecular mechanisms underlying the major depressive disorder (MDD) are still poorly understood, and current antidepressant treatments have limited clinical efficacy. In clinical conditions, the rapprochement between the disease and the corrective actions of drugs in laboratory animals is essential for developing effective therapies. Thus, the aim of this study was to evaluate the antidepressant effects of ketamine (N-metil-d-asparte (NMDA) receptor antagonist), minocycline (tetracycline antibiotic), and amitriptyline (classical antidepressant), on behavior and oxidative stress parameters in animals submitted to the chronic mild stress (CMS) and maternal deprivation protocols. For this aim, male Wistar rats were submitted to maternal deprivation or CMS. To induce maternal deprivation, Wistar rats were deprived of maternal care during the first 10days of life. To induce CMS, Wistar rats were submitted to the CMS for 40days. To reverse the effects of stress, treatment was done intraperitoneally with a single dose of ketamine (15mg/kg), and minocycline (25mg/kg) and amitriptyline (10mg/kg) by 20days. After treatment, the animals were submitted to the forced swimming test and then analyzed oxidative stress parameters in the prefrontal cortex (PFC), hippocampus, amygdala and nucleus accumbens (NAc). Treatment with ketamine, minocycline and amitriptyline were able to exert antidepressant effects in the forced swimming test. However, these antidepressant effects were dependent on the stress model by which the animals were exposed. In certain brain regions some treatment strategies had a pro-oxidant effect. Though, most of the strategies used in this study had antioxidant effects, as reported by a decrease on protein and lipid damage, nitrite/nitrate concentration and myeloperoxidase activity. In addition, an increase in the antioxidant superoxide dismutase (SOD) and catalase (CAT) enzymes activities were also evident after treatments. In conclusion, the antidepressant effects of ketamine and minocycline, in the present study, may be associated, at least in part, with its antioxidant and neuroprotective effects in animals subjected to maternal deprivation or CMS.",
     "CI": [
          "Copyright (c) 2017 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Maciel, Amanda L",
          "Abelaira, Helena M",
          "de Moura, Airam B",
          "de Souza, Thays G",
          "Rosa, Thayse",
          "Matos, Danyela",
          "Tuon, Talita",
          "Garbossa, Leandro",
          "Strassi, Ana Paula",
          "Fileti, Maria Eduarda",
          "Goldim, Mariana P",
          "Mathias, Khiany",
          "Petronilho, Fabricia",
          "Quevedo, Joao",
          "Reus, Gislaine Z"
     ],
     "AU": [
          "Maciel AL",
          "Abelaira HM",
          "de Moura AB",
          "de Souza TG",
          "Rosa T",
          "Matos D",
          "Tuon T",
          "Garbossa L",
          "Strassi AP",
          "Fileti ME",
          "Goldim MP",
          "Mathias K",
          "Petronilho F",
          "Quevedo J",
          "Reus GZ"
     ],
     "AD": "Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Fisiopatologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Fisiopatologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Fisiopatologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Fisiopatologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Fisiopatologia Clinica e Experimental, Universidade do Sul de Santa Catarina, Tubarao, SC, Brazil. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Center for Translational Psychiatry, Department of Psychiatry and Behavioral Sciences, Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA; Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA; Neuroscience Graduate Program, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA. Laboratorio de Neurociencias, Unidade Academica em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Electronic address: gislainereus@unesc.net.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20171215",
     "PL": "United States",
     "TA": "Brain Res Bull",
     "JT": "Brain research bulletin",
     "JID": "7605818",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Chronic mild stress",
          "Ketamine",
          "Major depressive disorder",
          "Maternal deprivation",
          "Minocycline",
          "Oxidative stress"
     ],
     "EDAT": "2017/12/19 06:00",
     "MHDA": "2017/12/19 06:00",
     "CRDT": [
          "2017/12/19 06:00"
     ],
     "PHST": [
          "2017/07/10 00:00 [received]",
          "2017/11/29 00:00 [revised]",
          "2017/12/04 00:00 [accepted]",
          "2017/12/19 06:00 [pubmed]",
          "2017/12/19 06:00 [medline]",
          "2017/12/19 06:00 [entrez]"
     ],
     "AID": [
          "S0361-9230(17)30392-1 [pii]",
          "10.1016/j.brainresbull.2017.12.005 [doi]"
     ],
     "PST": "aheadofprint",
     "SO": "Brain Res Bull. 2017 Dec 15;137:204-216. doi: 10.1016/j.brainresbull.2017.12.005.",
     "term": "hippocampus"
}